Cowealth Medical China Co.Ltd. (603122) — Capital Reinvestment Ratio
Cowealth Medical China Co.Ltd. (603122) has a Capital Reinvestment Ratio of 0.80x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥17.68 Million) in capital expenditures (CN¥14.21 Million). See Cowealth Medical China Co.Ltd. free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cowealth Medical China Co.Ltd. Capital Reinvestment Ratio (2020–2025)
This chart tracks Cowealth Medical China Co.Ltd.'s Capital Reinvestment Ratio across 5 annual periods.
Annual Capital Reinvestment Ratio for Cowealth Medical China Co.Ltd. (2020–2025)
Year-by-year Capital Reinvestment Ratio for Cowealth Medical China Co.Ltd. from 2020 to 2025. For live market cap and broader valuation context, see Cowealth Medical China Co.Ltd. (603122) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.80x | CN¥17.68 Million | CN¥14.21 Million | ▲ +235.2% |
| 2024 | 0.24x | CN¥132.75 Million | CN¥31.82 Million | ▼ -96.0% |
| 2023 | 6.02x | CN¥11.28 Million | CN¥67.96 Million | ▲ +90.9% |
| 2021 | 3.16x | CN¥7.01 Million | CN¥22.12 Million | ▲ +2785.6% |
| 2020 | 0.11x | CN¥74.15 Million | CN¥8.11 Million | — |